Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Unicycive Therapeutics ( (UNCY) ) is now available.
On May 21, 2025, Unicycive Therapeutics announced a change in the time of its 2025 Annual Meeting of Stockholders, which will now be held at 7:00 a.m. Pacific Daylight Time on June 9, 2025. The date and location remain unchanged, and stockholders of record as of April 30, 2025, can find participation details online. This announcement ensures stakeholders are informed of the updated schedule, maintaining transparency and engagement with the company’s stockholders.
The most recent analyst rating on (UNCY) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Unicycive Therapeutics stock, see the UNCY Stock Forecast page.
Spark’s Take on UNCY Stock
According to Spark, TipRanks’ AI Analyst, UNCY is a Underperform.
Unicycive Therapeutics has significant financial challenges, including ongoing net losses and a reliance on debt for financing, which weigh heavily on its stock score. The technical analysis reveals a bearish trend, as the stock is trading below major moving averages. Valuation metrics further dampen the attractiveness of the stock due to negative profitability indicators. Without earnings call insights or recent corporate events to improve prospects, the overall score reflects these financial and technical weaknesses.
To see Spark’s full report on UNCY stock, click here.
More about Unicycive Therapeutics
Unicycive Therapeutics is a biotechnology company focused on developing novel treatments for kidney diseases. Its lead investigational treatment, oxylanthanum carbonate, is under FDA review for hyperphosphatemia in dialysis patients, while UNI-494, intended for acute kidney injury, has received orphan drug designation for preventing Delayed Graft Function in kidney transplant patients.
Average Trading Volume: 873,507
Technical Sentiment Signal: Hold
Current Market Cap: $73.1M
Find detailed analytics on UNCY stock on TipRanks’ Stock Analysis page.